Pearce Samantha (CIK 1805688) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell JAZZ (2,527 shares), Buy JAZZ (6,907 shares), Sell JAZZ (6,907 shares), Sell JAZZ (2,503 shares), Buy JAZZ (9,782 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 2,527 | $600,718 |
| 2026-06-01 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Buy | 6,907 | $755,971 |
| 2026-06-01 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 6,907 | $1.6M |
| 2026-03-09 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 2,503 | $472,291 |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Buy | 9,782 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Buy | 3,637 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 1,599 | $273,685 |
| 2025-08-07 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 577 | $66,990 |
| 2025-03-07 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 1,905 | $264,700 |
| 2025-03-03 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Buy | 11,941 | $0 |
| 2025-03-03 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Buy | 5,778 | $0 |
| 2025-01-22 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Buy | 2,533 | $0 |
| 2025-01-22 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | Sell | 1,365 | $167,376 |
Source: SEC Form 4 filings · as of 2026-07-02